1	Residual disease after at least 6 cycles of anthracycline-based chemotherapy with residual disease defined as persistent bone marrow involvement and/or persistent measurable lymph node or solid organ masses that are PET or gallium avid|avid[231,235]||||||||||125679|125679|avid
1	Residual disease after at least 6 cycles of anthracycline-based chemotherapy with residual disease defined as persistent bone marrow involvement and/or persistent measurable lymph node or solid organ masses that are PET or gallium avid|gallium[223,230]|||||||||C0016980|1310124|1310124|gallium
